Nuclear localization marker of FOXO3a: can it be used to predict doxorubicin response?
Main Authors: | Chun eGong, Ui Soon eKhoo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00149/full |
Similar Items
-
Computational Identification and Modeling of Crosstalk between Phosphorylation, O-β-glycosylation and Methylation of FoxO3 and Implications for Cancer Therapeutics
by: Yigang Tong, et al.
Published: (2012-03-01) -
Role of FoxO Proteins in Cellular Response to Antitumor Agents
by: Giovanni Luca Beretta, et al.
Published: (2019-01-01) -
Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch
by: Mingge Ding, et al.
Published: (2022-06-01) -
Stem Cell Transcription Factor FoxO Controls Microbiome Resilience in Hydra
by: Benedikt M. Mortzfeld, et al.
Published: (2018-04-01) -
FoxO3 normalizes Smad3-induced arterial smooth muscle cell growth
by: Jake T. Francisco, et al.
Published: (2023-08-01)